| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.19B | -0.4% |
| Gross profit | ¥0.34B | — |
| Operating income | ¥0.10B | — |
| Net income | ¥0.09B | -30.5% |
| Gross margin | 28.3% | Net margin 7.5% |
| Revenue Q/Q | -12.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.85B | 71.7% |
| R&D | ¥0.10B | 8.1% |
| SG&A | ¥0.13B | 11.2% |
| Tax & other | ¥0.01B | 1.2% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
隆盛科技 ・ 英搏尔 ・ 朗新科技 ・ 海特生物 ・ 中石科技 ・ 艾德生物 ・ 智动力 ・ 赛意信息 ・ 创业黑马 ・ 澄天伟业 ・ 双一科技 ・ 联合光电
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies